Depression symptoms moderate the relationship between gray matter volumes and cognitive function in patients with

Yang Du1, Feng Yan1, Lu Zhao1

  • 1Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Alzheimer's Disease and Related Disorders Center, Shanghai Jiao Tong University, Shanghai, China.

Insights

Depression severity influences the link between brain structure and cognitive function in elderly individuals with mild cognitive impairment (MCI). This study highlights the importance of addressing depressive symptoms in MCI patients for better cognitive outcomes.

Area of Science:

  • Neuroscience
  • Gerontology
  • Psychiatry

Background:

  • Mild cognitive impairment (MCI) is associated with gray matter volume (GMV) changes and cognitive decline.
  • The impact of depressive symptoms on the relationship between GMV and cognitive function in MCI patients remains unclear.

Purpose of the Study:

  • To investigate the associations among depressive symptoms, GMV, and cognitive function in elderly individuals.
  • To explore the moderating role of depressive symptoms on the relationship between structural brain changes and cognitive function in MCI patients.

Main Methods:

  • Voxel-based morphometry (VBM) was used to compare GMV across 70 MCI patients with depressive symptoms (MCID), 70 MCI patients without depressive symptoms (MCIND), and 70 healthy controls (HCs).
  • Correlation and moderation analyses examined the relationship between GMV in specific brain regions and cognitive function, and the influence of depressive symptom severity.

Main Results:

  • MCIND patients showed decreased GMV in the bilateral fusiform gyrus, inferior temporal gyrus, parahippocampal gyrus, and hippocampus compared to HCs.
  • MCID patients exhibited reduced GMV in the bilateral fusiform gyrus compared to MCIND patients.
  • Depressive symptom severity significantly moderated the positive correlation between GMV in abnormal brain regions and cognitive function.

Conclusions:

  • This study reveals distinct patterns of GMV reduction in MCIND and MCID patients, suggesting specific neural mechanisms related to depressive symptoms in MCID.
  • Depressive symptoms play a crucial moderating role in the association between brain structure and cognitive function in elderly MCI patients.
  • Clinical interventions targeting depressive symptoms are significant for managing cognitive function in elderly MCI patients.

Related Concept Videos

Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
132
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
319
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
380
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
226
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
692
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
174